Hypertension (HTN)
Normal = <120/80
Elevated = 120-129/80
Hypertension
- Stage 1 = SBP 130-139 or DBP 80-89 
- Stage 2 = SBP >140 or DBP > 90 
24-hour ambulatory definitions of HTN
- Average of >125/75 
- Day >130/80 
- Night >110/65 
Primary HTN Risk Factors:
- Age 
- Obesity 
- Family history 
- Fewer nephrons 
- High sodium diet 
- Excess alcohol 
- Physical inactivity 
- Social determinants 
Secondary causes
Medications
- Oral contraceptive 
- NSAIDs 
- Antidepressants 
- Corticosteroids 
- Decongestants 
- Weight loss medications 
- Stimulants 
Illicit drugs
Primary kidney disease
Primary aldosteronism
Renovascular hypertension
Obstructive sleep apnoea
Phaeochromocytoma
Coarctation of the aorta
Endocrine conditions
- Cushing’s Syndrome 
- Hypothyroidism 
- Hyperthyroidism 
- Hyperparathyroidism 
Complications of HTN
Risk begins to start with blood pressure >115/75
For every 20/10 increase, the risk of death from heart disease doubles
- Left ventricular hypertrophy 
- Heart failure 
- Ischaemic stroke 
- Intracerebral bleed 
- Ischaemic heart disease 
- Chronic kidney disease 
Evaluation
Once established check for
- The extent of end-organ damage 
- Presence of CVD or CKD 
- Check cardiovascular risk factors 
- Lifestyle factors that could contribute 
- Potential interfering substances 
Tests
- FBC, UEC, Lipids, Glucose, TSH, CMP 
- ECG 
- Calculate 10-year risk 
- Urinalysis + ACR 
- Consider echo 
- Consider testing secondary causes but these are rare 
Treatment
- Weight loss 
- Less salt 
- More potassium 
- Healthy diet 
- Exercise 
- Less Alcohol 
Outcomes
Treatment with medication produces
- 50% risk reduction in heart failure 
- 35% risk reduction in stroke 
- 25% risk reduction in heart attack 
This means 100 patients need to be treated for 5 years to prevent an adverse cardiovascular event in 2 patients.
Medication
Three primary options for most patients
- ACEI or ARB 
- Calcium channel blocker 
- Thiazide 
Start at the lowest dose
- If not to target add 2nd agent 
- Titrate up one of the agents 
- If still not at target, add a third agent 
Combinations to avoid
- ACE inhibitor or ARB plus potassium-sparing diuretic – risk of hyperkalaemia. 
- beta blocker plus verapamil or diltiazem – risk of heart block. 
- ACE inhibitor plus ARB – increased risk of hypotensive symptoms, syncope, and renal dysfunction. 
- Thiazide diuretic and betablocker – not recommended in patients with glucose intolerance, metabolic syndrome, or established diabetes. 
- NSAIDs with ACE inhibitors, ARB, diuretics, and beta blockers. 
Effective combinations
- ACEI or ARB and Ca2+ blocker – Diabetes or lipid abnormalities 
- ACEI or ARB and thiazide diuretic – Heart failure, or post stroke 
- ACEI or ARB and beta blocker – Myocardial infarction (MI) or heart failure 
- Beta blocker and dihydropyridine calcium channel blocker – Heart disease 
Reference:
- Hypertension - UpToDate 
- Hypertension - HNE Pathways 
